Emerging Opportunities in Biodefense; An interview with Aethlon Medical (OTCBB: AEMD)

CEO, Jim Joyce

Point Roberts, WA. March 25, 2011 – Investorideas.com, a leader in sector research including

biotech and biodefense stocks, presents an interview with Jim Joyce, CEO of Aethlon Medical

(OTCBB: AEMD).

InvestorIdeas: What opportunities exist for small organizations that want to participate in

the emerging biodefense industry?

Jim Joyce, CEO of Aethlon Medical (OTCBB: AEMD)

Multiple opportunities have recently surfaced for small organizations with innovative

countermeasures against bioterror threats, and more are expected in the near future. As an

example, Freemind Group, an industry advisory organization reported this week that they are

witnessing a dramatic and unprecedented surge in biodefense and infectious disease funding

opportunities from various government institutes. They anticipate that funding applications

submitted during the coming months of May, June, and July alone will result in cumulative awards

of approximately $500,000,000.00. In fact, some of these awards are not capped and can exceed

$50,000,000 for clinical trial support. For small organizations, such non-dilutive awards offer to

transform business capabilities and reward patient shareholders.

InvestorIdeas: That’s certainly exciting, but how can small organizations like Aethlon

Medical compete against big pharma for such awards?

Jim Joyce, CEO of Aethlon Medical

In reality, both big pharma and large biotechnology players have demonstrated little interest

in responding to these programs. As a result, government agencies are primarily reliant on

innovation stemming from research advanced by small organizations, which from a historical

basis, is likely to be the principal source of innovation anyway. Still, these programs do not

exist to solely support research. Recently created agencies like the Biomedical Research and

Development Authority (known as BARDA) provide support for post R&D activities including

clinical studies, manufacturing, and other activities that may be required to transition a candidate

treatment countermeasure into the strategic national stockpile.

InvestorIdeas: Do you feel Aethlon Medical is positioned to benefit from these programs?

Mr. Joyce: I feel we are extremely well positioned to benefit as government policies to protect

against bioterror and pandemic threats have been redefined to focus support towards broad-

spectrum countermeasures that are able to address multiple pathogen threats. Based on pre-

clinical and clinical data, we believe our Hemopurifier® is the most advanced and perhaps only

true broad-spectrum countermeasure. While traditional therapeutics often struggle to address

multiple strains of the same pathogen, third party researchers have demonstrated that our

Hemopurifier® captures different species of many of the most deadly viral threats known to man.

These include Dengue, Ebola, and Lassa Hemorrhagic Viruses, West Nile Virus, H5N1 Avian

Influenza Virus, the 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918, and

Monkeypox Virus, which is the primary model for testing treatments against human Smallpox

infection.

InvestorIdeas: Have you conducted any human studies with your Hemopurifier®

Jim Joyce, CEO of Aethlon Medical

Yes, we have advanced our technology into human studies, which demonstrated safety and the

observation of significant viral load reductions in both hepatitis-C and HIV infected individuals

without the administration of antiviral drug therapies. We are now advancing a clinical program

whose objective is to utilize our Hemopurifier® as an adjunct strategy to improve the benefit

of hepatitis-C standard-of-care drug therapy without adding drug toxicity and interaction risks.

We are quite excited about this clinical program, as therapeutic filtration of hepatitis-C from

plasma has previously proven to have a remarkable effect in improving treatment outcomes

when combined with drug therapy.

opportunity, I feel confident that we are advancing a leading broad-spectrum therapeutic strategy

to address viral threats, and that our strategy fulfills strategic objectives recently mandated by

our government.

treatment countermeasures that may also have mainstream commercial market applications in

disease conditions such as hepatitis-C, HIV, and cancer.

InvestorIdeas: Is Aethlon Medical currently pursuing any contract or grant opportunities?

Jim Joyce, CEO of Aethlon Medical
Yes. In the coming days we will submit a formal response to a military program opportunity
entitled “Dialysis Like Therapeutics”. The stated goal of this program is the creation of a medical
device that would save the lives of thousands of military patients each year. While our response
is challenging, it has also been rewarding as we have attracted several groups to partner and
participate in our submission. Once our response is in, we will then convene with our advisors to
determine the next contract opportunity to focus our efforts towards.

InvestorIdeas: In closing, is there any advice you would provide to other organizations

that might be interested in participating in the biodefense and pandemic threat industry?

Jim Joyce, CEO of Aethlon Medical

By nature, the opportunity to address the looming threat of biological weapons and naturally

Regardless, as it specifically relates to our biodefense

We also benefit from a policy shift that no longer precludes the support of

emerging pandemic threats will be enduring and the industry is still very young. However, my

advise for small organizations is to be sure they have therapeutic strategies in place to address

established disease conditions with real commercial markets before venturing into a field where

targeted disease conditions may or may not emerge and the primary source of support is

government funding.

About Aethlon Medical (OTCBB: AEMD)

At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer.
Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in
disease diagnosis and monitoring.

Our Hemopurifier® is the first medical device to selectively target the removal of infectious
viruses and immunosuppressive proteins from the entire circulatory system. We recently
discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune
system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly
inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer
care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need
and provide the benefit of an immune-based therapy without adding drug toxicity or interaction
risks to established and emerging treatment strategies.

Human studies have documented the ability of our Hemopurifier® to safely reduce viral load
in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients
without the administration of antiviral drugs. However, our initial clinical and commercialization
focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both
infectious disease and cancer treatment regimens. In this regard, we plan to commercialize
our Hemopurifier® in India as we advance our clinical strategies in the United States and the
European Union. In vitro studies conducted by government and non-government research
institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against
bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue
Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1
Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus,
and Monkeypox Virus, which serves as a model for human Smallpox infection.

As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market
opportunities:
1. Cancer: A treatment candidate to improve patient responsiveness to established cancer
therapies by removing immunosuppressive exosomes from circulation.
2. Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset
of standard of care drug regimens.
3. Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected
individuals to manage disease progression once they become resistant to antiviral drug regimens.
4. Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to
address untreatable bioterror and emerging pandemic threats.

The Hemopurifier® is an expansive multi-patented platform technology whose mechanism
of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery
solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed
for implementation within the established infrastructure of dialysis machines and other blood
circulatory pumps already located in hospitals and clinics worldwide.

In design, our Hemopurifier® is a selective filtration device containing affinity agents that
tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer

and glycoproteins residing on the envelope of viruses. These agents are immobilized around
approximately 2800 porous hollow fibers that run the interior length of our device. The resulting
design provides us the novel ability to separate both exosome and viral targets away from blood
cells so they can then be selectively and permanently removed from the circulatory system. In
application, blood circulation is established into the Hemopurifier® via a catheter or other blood
access device. Once blood flow has been established, treatment benefit is immediate as the
entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.

Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of
exosome-targeted products and services that improve cancer diagnosis, provide post-treatment
cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient
therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be
accessed online at www.aethlonmedical.com.

Certain of the statements herein may be forward-looking and involve risks and uncertainties.
Such forward-looking statements involve assumptions, known and unknown risks, uncertainties
and other factors which may cause the actual results, performance or achievements of Aethlon
Medical, Inc. to be materially different from any future results, performance, or achievements
expressed or implied by the forward-looking statements. Such potential risks and uncertainties
include, without limitation, the company's ability to commercialize its Hemopurifier® in India,
capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or
treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes
and the impact that potential ability may have on disease conditions, the Company's ability to
raise capital when needed, the Company's ability to complete the development of its planned
products, the ability of the Company to obtain FDA and other regulatory approvals permitting
the sale of its products, the Company's ability to manufacture its products either internally or
through outside companies and provide its services, the impact of government regulations, patent
protection on the Company's proprietary technology, product liability exposure, uncertainty of
market acceptance, competition, technological change, and other risk factors. In such instances,
actual results could differ materially as a result of a variety of factors, including the risks
associated with the effect of changing economic conditions and other risk factors detailed in the
Company's Securities and Exchange Commission filings.

Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized
in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.

Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/
Stock_List.asp

Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD

Get added to the company’s news alerts:
http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research
Our sites do not make recommendations, but offer information portals to research news,
articles, stock lists and recent research. Nothing on our sites should be construed as an offer or

solicitation to buy or sell products or securities. This site is currently compensated by featured
companies, news submissions and online advertising. AETHLON MEDICAL INC (OTC BB:
AEMD) Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand
five hundred per month, $five thousand per month in 144 stock) Effective March 15, 2011

800-665-0411 – dvanzant@investorideas.com
Source - Investorideas.com

Gold Stock Running Fox (TSX-V: RUN) Trading up over 8% on Recent News; Follow on to Yesterday's Trading

POINT ROBERTS, Wash., March 24, 2011 - www.InvestorIdeas.com, a leader in sector research for investors including mining stocks, features a gold stock trading alert on Running Fox Resources, (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q). Following yesterdays news on its New Mexico project drilling, the stock was up 10%. The stock is trading this morning at $ 0.26, up another 0.02 (8.33%).
Running Fox (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q) is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
www.foxgold.ca
Recent News:
Running Fox Resource Corp. New Mexico Project Drilling

Steve Schurman, CEO, Director, reports:
Running Fox Resources, (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
The Company reports that diamond drilling has now started on a multi-hole drill program on Running Fox''s 100 % owned New Mexico project located south of Grants, New Mexico. Strategic Resources has optioned the property and is drilling to earn a 50 % interest, and may earn up to a 60 % interest upon delivery of a bankable mine feasibility study.
Running Fox also reports that its acquisition of the remaining 50 % of the Brett Gold and Silver Project is being finalized and Company plans to announce completion soon.
On Behalf of the Board of Directors, Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
About our Mining Portals:
www.Gold-MiningStocks.com and www.MiningSectorStocks.com are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1200 mining stocks.
Gold and Mining Stocks: over 1200 listed stocks
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1200 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges.
http://www.investorideas.com/Gold_Stocks/Stocks_List.asp
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclosure: The following news is paid for and /or published as information only for our readers. Running Fox Resource Corp. (TSX.V: RUN) for three days or press release services (seven hundred)
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

"Wall Street Economics is Bad for Innovation"- Levine's MicroCap Investor

Functional Inspiration Blog: Money and Innovation in the Microsphere, by Josh Levine

Wall Street Economics is Bad for Innovation
March 23, 2010
By Josh Levine
Learn more about subscribing to Levine�s MicroCap Investor:
http://www.levinesmicrocapinvestor.com/subscriptions/order/

The institutionalization of finance has been good for Wall Street power brokers, enabling them to concentrate control and profits. But it has done absolutely nothing to improve the environment for small innovative companies seeking to raise $5 million, $20 million, or $50 million. In fact, it has sucked capital away from emerging growth firms and into a mundane mosaic of investments – everything from securitized mortgages to ETFs of every stripe.
The matra of "bigger is better" means investment bankers, hedge funds, venture capitalists and others can earn bigger fees, but it creates a huge vacuum in the system. Too much risk (and intellectual) capital is being channeled into casino-like trading and a range of investment gimmicks rather than serving growth companies and research and development.
The model for funding small innovative firms has been broken for many years, and the economic and opportunity costs are killing us.
Until a better system emerges, many of the most challenging economic problems faced by the United States, including terminal unemployment, decline in leadership of innovation-driven markets, and shrinking capital markets for emerging growth companies, may never be fully reversed.
One of the most effective ways to improve the situation is by changing the incentive system for financing small technology companies.
As two senior advisors at Grant Thornton -- Edward Kim and David Weild -- correctly point out, markets have become inhospitable to smaller private companies looking to raise less than $50 million.
CFO magazine, reporting on their recent testimony for a U.S. congressional subcommittee, says:
"The main cause, as they see it, is lower trading fees, stemming first from online brokerages and new order-handling rules in the late 1990s, and then from decimalization, Sarbanes-Oxley, and the global research analyst settlement separating research from banking. Given the lower fees, it no longer makes economic sense for investment banks to support small-company IPOs with capital and research. Kim says that small companies 'are not a product anymore; they're just food for Goldman Sachs's real clients'— hedge funds looking for quick gains through IPOs…"
Without a major revision of the economic incentives for funding and supporting small companies, we're stuck with a busted system for financing innovation. And while the passage of the Small Company Capital Formation Act of 2011 (a bill that would increase the amount of money companies can raise in the public markets through Reg A transactions from $5 million to $50 million) would help the situation, it will fall far short of what's really needed.
According to Kim, raising the limit to $50 million "would be a positive step that would reduce some red tape, and one that I think Congress will pass, but it's just one step of many that would be needed. I truly believe that without a completely different market model, we won't fix the problems."
Clearly, there is no simple cure for what ails innovation financing. While a new Reg A limit would at least be a first step towards improving market conditions for the companies that have the potential to transform the U.S. economy, there's much more that can, and should, be done.
In an upcoming entry for Functional Inspiration, I will explore some initiatives that could create better opportunities for smaller companies to access capital and accelerate the development of emerging technologies into the marketplace.
Subscribe to Functional Inspiration Blog http://www.levinesmicrocapinvestor.com/RSS/Articles.xml
MicroCap Investor delves deep into the world of small stocks to identify big winners. Levine targets innovative companies on the path of the new and revolutionary, developing technologies that disrupt entrenched markets to create tremendous value.
About Josh Levine and Levine's MicroCap Investorwww.levinesmicrocapinvestor.com
Josh Levine has 25 years of senior-level experience in analyzing technology trends and investing in top-performing micro- and small-cap stocks. He excels at assessing management teams and evaluating new innovations and their impact on corporate valuations.
In 2002 he joined independent investment-research boutique ChangeWave Research, where he was editor of ChangeWave MicroCap Investor since 2004, becoming Levine's MicroCap Investor in 2010. He has been editor of the flagship ChangeWave Investing since 2007.
Levine is also senior analyst for ChangeWave Research. Through its survey network comprised of 25,000 members, ChangeWave tracks the rate of change in corporate and consumer demand trends and provides the results through an institutional research subscription service. Its macroeconomic research is among the best on Wall Street.
More on Levine's bio: http://www.levinesmicrocapinvestor.com/aboutus/
Learn more about subscribing to Levine's MicroCap Investor: http://www.levinesmicrocapinvestor.com/subscriptions/order/
InvestorIdeas.com is partnered with Josh Levine and MicroCap Investor as part of its mission to provide investors with research tools to explore the world of small stocks. The InvestorIdeas.com team operates this web site and manages the administration and marketing for MicroCap Investor.
InvestorIdeas.com is a leading investment and industry research portal, with resources covering high-growth sectors including technology, biotech and cleantech.
Levine's MicroCap Investor
Contact us
admin@levinesmicrocapinvestor.com
800 665 0411

TSX Gold and Mining Stocks Alert; Running Fox (TSX-V: RUN); Trading up 10.20% on News on New Mexico Project

POINT ROBERTS, Wash., March 23, 2011 - www.InvestorIdeas.com, a leader in sector research
for investors, features a mining stock alert on Running Fox Resources, (TSX-V:RUN) (US
OTC:RFXRF) (FRANKFURT:C8Q) following news on its New Mexico project drilling released
today. The stock is trading is trading at $ 0.27, up 0.03 (10.20%).

Running Fox (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q) is a Canadian growth-
oriented resource company with mineral projects including US uranium and Canadian gold
properties, oil and gas assets, and oilfield service operations.
www.foxgold.ca

Today’s News:
Running Fox Resource Corp. New Mexico Project Drilling

Steve Schurman, CEO, Director, reports:
Running Fox Resources, (TSX-V: RUN) (US OTC: RFXRF) (FRANKFURT: C8Q)

The Company reports that diamond drilling has now started on a multi-hole drill program on
Running Fox''s 100 % owned New Mexico project located south of Grants, New Mexico. Strategic
Resources has optioned the property and is drilling to earn a 50 % interest, and may earn up to a
60 % interest upon delivery of a bankable mine feasibility study.

Running Fox also reports that its acquisition of the remaining 50 % of the Brett Gold and Silver
Project is being finalized and Company plans to announce completion soon.

On Behalf of the Board of Directors, Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca

About our Mining Portals:
www.Gold-MiningStocks.com and www.MiningSectorStocks.com are research portals within the
InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and
financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory
of over 1200 mining stocks.

Gold and Mining Stocks: over 1200 listed stocks

Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists
over 1200 publicly traded mining companies. Mining and metals investors can research gold and

mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium
Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading Stock Exchanges.
http://www.investorideas.com/Gold_Stocks/Stocks_List.asp

Sign up for the free investor news letter and get stock alerts in leading sectors!

http://www.investorideas.com/Resources/Newsletter.asp

About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing
content.

Disclosure: The following news is paid for and /or published as information only for our readers.
Running Fox Resource Corp. (TSX.V: RUN) for three days or press release services (seven
hundred)
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly,
but we offer no guarantees as to the accuracy of information presented. All Information relating to
featured companies is sourced from public documents and/ or the company and is not the opinion
of our web sites. This site is currently compensated by featured companies, news submissions
and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

For Additional Information 800 665 0411 cvanzant@investorideas.com

Source – Investorideas.com

TSX Gold and Mining News; Running Fox Resource Corp. (TSX-V:RUN) New Mexico Project Drilling

Investorideas.com Mining Newswire - March 23, 2011
Steve Schurman, CEO, Director, reports: Running Fox Resources, (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q)

The Company reports that diamond drilling has now started on a multi-hole drill program on Running Fox''s 100 % owned New Mexico project located south of Grants, New Mexico. Strategic Resources has optioned the property and is drilling to earn a 50 % interest, and may earn up to a 60 % interest upon delivery of a bankable mine feasibility study.
Running Fox also reports that its acquisition of the remaining 50 % of the Brett Gold and Silver Project is being finalized and Company plans to announce completion soon.
Running Fox (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q) is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
www.foxgold.ca
On Behalf of the Board of Directors, Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Investorideas.com news Disclosure: The following news is paid for and /or published as information only for our readers. Running Fox Resource Corp. (TSX.V: RUN) for three days or press release services (seven hundred)

Biodefense Stocks /Homeland Defense Stock Alert; Dynasil Corporation (NASDAQ GM:
DYSL) trading at $6.26, up 2.50 (66.49%)

Radiation Fears and Biological Warfare Threats Raise Investor Interest in Biodefense Stocks;
(OTCBB: AEMD), (NASDAQ GM: DYSL), (NYSE Amex: PIP), (NasdaqGM: SIGA )

Point Roberts, WA- March 23, 2011 - Investorideas.com, a leader in investor sector research
including Homeland Defense and Biodefense Stocks issues a trading alert on the sector as
Dynasil Corporation of America(NasdaqGM: DYSL ) becomes the top gainer on the NASDAQ on
patent news for its radiation monitoring device.

Dynasil Corporation (NASDAQ GM:DYSL), announced today that its research division, Radiation
Monitoring Devices, Inc. (RMD), also of Watertown, was granted additional U.S. patent claims for
advances in a detector material capable of responding independently to both neutron and gamma
radiation. This advancement is of critical national importance because the most commonly
available technology for detecting neutrons in Homeland Security applications, specifically
neutron detectors based on gaseous Helium-3, is becoming impractical because of serious
limitations on the availability of this gas.



In a recent article on Daily Finance entitled “Inside Wall Street: Looking to the Bio-Defense
Sector as Nuclear Fears Mount”, notes - The sector attracted a lot of interest after 9/11 and a
number of companies emerged to develop protective biodefense drugs and products. But with the
waning of dark headlines about terrorist threats, investors have tended to put them on their low-
priority list.
That may be about to change

Full article : http://www.dailyfinance.com/story/stock-picks/inside-wall-street-looking-to-bio-defense-sector-as-
nuclear-fea/19880106/

Biodefense Stocks Sector Snapshot
Aethlon Medical (OTCBB: AEMD) trading at $0.14
Dynasil Corporation (NASDAQ GM: DYSL) trading at $6.26, up 2.50 (66.49%) 12:21PM EDT
Emergent Biosolutions, Inc. Com (NYSE: EBS ) trading at $23.53, down 0.04 (0.17%) 12:29PM
EDT
PharmAthene, Inc. (NYSE Amex: PIP) trading at $3.42, up 0.01 (0.29%) 12:27PM EDT
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) trading at $0.32
Siga Technologies (NasdaqGM: SIGA ) trading at $12.27, up 0.25 (2.08%) 12:29PM EDT

Research more Biodfense stocks at Investorideas.com
http://www.investorideas.com/bds/stock_list.asp

Biodefense Company Snapshot

Aethlon Medical (OTCBB: AEMD)
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer.
Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in
disease diagnosis and monitoring.

Our Hemopurifier® is the first medical device to selectively target the removal of infectious
viruses and immunosuppressive proteins from the entire circulatory system. We recently
discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune
system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly
inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in
cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet
clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or
interaction risks to established and emerging treatment strategies.
More: www.aethlonmedical.com
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com

Visit the Aethlon Medical ( OTCBB:AEMD) showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD

Get added to the company’s news alerts:
http://www.investorideas.com/Resources/Newsletter.asp

About InvestorIdeas.com:

InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector
investing, including biotech stocks with its portal BiotechIndustryStocks.com.

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make

recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our
sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated
by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD )
Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five
thousand per month in 144 stock)Effective March 15, 2011
Aethlon Medical ( OTCBB:AEMD) :Certain of the statements herein may be forward-looking and involve risks and
uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially
different from any future results, performance, or achievements expressed or implied by the forward-looking statements.

800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Mining Stock Investor Alert for Katanga Mining Limited (TSX: KAT)

POINT ROBERTS, Wash., March23, 2011 - www.InvestorIdeas.com, a leader in sector research for investors, features a mining stock alert for Katanga Mining Limited (TSX: KAT), trading up at $1.77, up 0.23 (14.94%) in early morning trading, making it one of the top gainers.
About Katanga Mining Limited
Katanga Mining Limited operates a major mine complex in the Democratic Republic of Congo producing refined copper and cobalt. The Company has the potential to become Africa's largest copper producer and the world's largest cobalt producer. Katanga is listed on the Toronto Stock Exchange under the symbol KAT. www.katangamining.com

Investorideas.com features investor research tools for mining investors including its stock directory, Mining stocks newswire and featured showcase mining stocks.
Subscribe to the mining newswire: http://www.investorideas.com/RSS/feeds/Gold-Mining-Stocks.xml
About our Mining Portals:
www.Gold-MiningStocks.com and www.MiningSectorStocks.com are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1200 mining stocks.
Investorideas.com resource stock directories for investors:
Gold and Mining Stocks: over 1200 listed stocks
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1200 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges.
http://www.investorideas.com/Gold_Stocks/Stocks_List.asp
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format, features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Investorideas.com members can access all energy stock directories, in addition to biotech, nanotech, water, defense and the newly added tech stocks for cloud computing and social network stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclosure: Investorideas.com was not compensated by Katanga Mining
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Biodefense Stocks Snapshot; (OTCBB: AEMD), (NasdaqCM: CBLI), (NYSE Amex: PIP), (NasdaqGM: SIGA)

Point Roberts, WA - March 22, 2011 - Investorideas.com, a leader in investor sector research including biotech and biodefense stocks looks at some of the biotech stocks developing technologies and products to deal with news headlines of �radiation leaks and biological warfare�. Biodfense stocks have not been in the investor spotlight in recent years as Bioterrorism fears subsided and new issues took the forefront for Wall Street.

A major trigger for the sector are the global concerns and fears that Libyan leader, Colonel Muammar Gaddafi will potentially use biological and chemical weapons.
In a recent article on Daily Finance entitled "Inside Wall Street: Looking to the Bio-Defense Sector as Nuclear Fears Mount", notes - The sector attracted a lot of interest after 9/11 and a number of companies emerged to develop protective biodefense drugs and products. But with the waning of dark headlines about terrorist threats, investors have tended to put them on their low-priority list.
That may be about to change
Full article : http://www.dailyfinance.com/story/stock-picks/inside-wall-street-looking-to-bio-defense-sector-as-nuclear-fea/19880106/
Following 911, Project Bioshield Act was passed by Congress in 2004 calling for $5 billion for purchasing vaccines to be used in the event of a bioterrorist attack. Biotech companies continued to move forward with solutions as investors moved on to other sectors.
According to a recent article in Bioprepwatch.com, "Bioterrorism, in my view, is the most serious and likely threat to our national security, "Simon said, SNCTimes.com reports.
Full article : http://www.bioprepwatch.com/news/236579-expert-warns-of-bioterrors-ability-to-undermine-america
Chairman and CEO of Aethlon Medical, Inc.(OTCBB: AEMD) recently updated his shareholders regarding their biodfense efforts in letter March 15 th .
"As we advance our Hepatitis-C (HCV) treatment studies in India, we have also been active in our efforts to benefit from new government policies aimed at protecting U.S. civilian and military populations from bioterror and pandemic threats."
Mr. Joyce went on to say, :Earlier this year, we were honored to be invited by The Department of Health and Humans Services (HHS) to present our Hemopurifier® as a broad-spectrum platform technology to multi-agency health officials on January 12th at the Washington Convention Center. Since this presentation, our bioterror and pandemic threat initiative has led to follow-on meetings and presentations, including a formal presentation to the Biomedical Advanced Research and Development Authority (BARDA) on February 15th. "
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, reported last month " that new pharmacokinetic data from the Company's Valortim® anthrax anti-toxin program were presented at the 9th Annual ASM Biodefense and Emerging Diseases Research Meeting, held in Washington, DC, February 6-9, 2011. The data were presented by Dr. Elizabeth Leffel, Director of Non-Clinical Sciences for PharmAthene, in a poster presentation entitled, "Pharmacokinetics of a Monoclonal Anthrax Anti-Toxin Antibody in Healthy and Infected Cynomolgus Macaques."
Biodefense Stocks Sector Snapshot

• Aethlon Medical (OTCBB: AEMD) trading at $0.14
• Cleveland BioLabs (NasdaqCM: CBLI ) trading at $7.35, up 0.19 (2.65%) 10:10AM EDT
• Emergent Biosolutions, Inc. Com (NYSE: EBS ) trading at $23.59, up 0.02 (0.08%) 10:33AM EDT
• PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, trading at $3.42, up 0.01 (0.29%) 10:31AM EDT
• Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) trading at $0.33
• Siga Technologies (NasdaqGM: SIGA ) trading at $11.83, down 0.28 (2.31%) 10:35AM EDT
• Soligenix, Inc. (OTCBB:SNGX) trading at $0.20

Research more Biodfense stocks at Investorideas.com
http://www.investorideas.com/bds/stock_list.asp
Market Snapshot

• Dow 12,027.75 -8.78 -0.07%
• NASDAQ 2,690.32 -1.77 -0.07%
• S&P 500 1,296.45 -1.93 -0.15%
• 10 Yr Bond(%) 3.3390% +0.0160
• Oil 102.45 +0.13 +0.13%
• Gold 1,426.20 0.00 0.00

Biodefense Company Snapshot
Aethlon Medical ( OTCBB:AEMD)
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
More: www.aethlonmedical.com
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Visit the Aethlon Medical ( OTCBB:AEMD) showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get added to the company's news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011     
Aethlon Medical ( OTCBB:AEMD) :Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.  
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Gold and Mining Stock News Alert; (TSX-V: RUN), (TSX: LSG), (TSX: AVR), (TSX:  CPN)

Point Roberts WA- March 22, 2011 (Investorideas.com Mining Newswire) –
www.Investorideas.com, a leader in sector research including mining stocks, releases a sector
snapshot on TSX gold stocks , in addition to commentary on the gold markets.

Regular contributor , John Nadler from Kitco.com reports, “Tuesday's trading action opened
under somewhat more subdued conditions as a slight easing in the level of apprehensions
surrounding Japan and the MENA region induced global investors to seek profits in equity and
risk markets just a tad more. Dollar selling did not abate too much however, as the US currency
scraped the 75.28 level on the index and as it neared the "outer markers" of its trading channel
against the euro, at 1.424, while trading at 80.925 vis a vis the Japanese yen.”
Full article : http://www.investorideas.com/news/2011/mining/03221.asp

Market Summary for Commodities (at time of release)
Oil 103.80 +1.47 +1.44%
Gold 1,426.20 0.00 0.00%

A more bullish outlook was reported at Marketwatch.com
Gold futures turned edged higher Tuesday morning, rebounding from an earlier decline
with the metal poised to extend its winning streak to five sessions.

A stronger yen helped lure investors to the gold market, according to one strategist.
“We see no fundamental reasons this morning for strong gold, but we are beginning to see
evidence of Japan probably increasing demand for gold, and some other banks may be buyers in
order to add to the portfolio just in case Japan sells gold later this year to fund its rebuilding,” said
Richard Hastings, a macro strategist at Global Hunter Securities.”
Full Article: http://www.marketwatch.com/story/gold-turns-higher-set-to-extend-winning-streak-2011-03-22?

siteid=yhoof

Resource Stocks trading; Gold Stocks
Trading March 22nd (at time of release)
AVION GOLD CORP (TSX: AVR) trading at $1.65, up 0.15 (10%) on over 2 Million shares in
Volume
Lake Shore Gold Corp (TSX: LSG) trading at $4.02, up 0.04, (1.01%)
Running Fox Resource Corp. (TSX-V: RUN) trading at $0.24 up 0.02, (8.89%)
Rainy River Resource Ltd. (TSX-V: RR) trading at $10.84
Carpathian Gold Inc. (CPN.TO) trading at $0.52, up 0.05 (10.64%) on over 1 Million shares in
volume

GOLD NEWS AND HIGHLIGHTS:
Recent Gold Stocks News; Running Fox Resource Corp. (TSX-V: RUN)
Gold and Mining Stocks; Running Fox Resource Corp. (TSX.V: RUN) Approves High Grade
Gold Project-SEE DRILL TABLE BELOW
Visit this company: www.foxgold.ca

“VANCOUVER, BRITISH COLUMBIA - February 23, 2011 (Investorideas.com newswire) Steven
Schurman, P. Geol (US), CEO, Director, reports:

Running Fox Resources (TSX VENTURE:RUN; PINK SHEETS:RFXRF; FRANKFURT:C8Q) is
pleased to report that it has received formal Toronto Stock Exchange - Venture approval for its
agreement to acquire the remaining 50% of the its high grade Brett Gold Project, Running Fox will
then own 100%.

The Teck Cominco smelter receipts for the net recovered grades for the whole bulk sample
proved ore averaged 28 grams per tonne gold plus 64 grams per tonne silver.

A review of drilling results at the Brett Gold Project includes 16 metres of 35 grams per ton gold.”
Full Article: http://www.investorideas.com/news/2011/mining/02231.asp
More info :
Running Fox Resource Corp. www.foxgold.ca

Recent Gold Stocks News; Lake Shore Gold Corp (TSX: LSG)
Lake Shore Gold Achieves Major Milestones in 2010, on Track to Nearly Triple Production
and Significantly Grow Resources in 2011

“TORONTO, ONTARIO--( March 9, 2011) - Lake Shore Gold Corp. (TSX:LSG -; "Lake Shore
Gold" or "the Company") today reported financial and operating results for the fourth quarter and
full year 2010. Among highlights of the results:
- Progress in 2010 leads to commercial production effective January 1, 2011, positions Company
to nearly triple production in 2011 to 125,000 ounces
-Target production rates at Timmins Mine achieved in fourth quarter 2010
-Mill expansion completed in November, recoveries exceed 95% target level;
-29,900 ounces of gold produced during fourth quarter 2010 (43,500 ounces for full year)”
Full Article: http://finance.yahoo.com/news/Lake-Shore-Gold-Achieves-ccn-
319006120.html?x=0&.v=1

Recent Gold Stocks News: Carpathian Gold Inc. (CPN.TO)
Carpathian Intersects 482 m of 1.06 g/t Au & 0.21% Cu and Continues to Increase Size of
Ciresata Deposit With More Wide Zones of Au-Cu Mineralization

“TORONTO, ONTARIO--( March 22, 2011) - Carpathian Gold Inc. (TSX:CPN -; the "Corporation"
or "Carpathian") is pleased to provide further results from its 35,000 meter planned 2011
drill program at the Corporation's 100% owned Rovina Valley Project ("RVP") in west-central
Romania. The RVP includes three Au-Cu porphyries discovered by the Corporation with the focus
of the 2011 drilling program on the Au-rich Ciresata Porphyry deposit. The 2011 drill program
will focus on defining the limits of the Ciresata deposit, upgrade the inferred resource to the
measured plus indicated resource categories, as well as test satellite targets.”
Full Article: http://finance.yahoo.com/news/Carpathian-Intersects-482-m-ccn-
3616713870.html?x=0&.v=1

Recent Gold Stocks News: AVION GOLD CORP (TSX: AVR)
Avion Gold Announces Fourth Quarter Earnings of US$0.05 Per Share and Cashflow of
US$0.08 Per Share

“TORONTO, ONTARIO--(Marketwire - March 21, 2011) - Avion Gold Corporation (TSX:AVR -
News; OTCQX:AVGCF) ("Avion" or the "Company") today announces its financial results for
the fourth quarter and year ended December 31, 2010. All amounts are in United States dollars
unless otherwise indicated.”
Full News: http://finance.yahoo.com/news/Avion-Gold-Announces-Fourth-ccn-
3541855622.html?x=0&.v=1

Published at Investorideas.com and www.Gold-MiningStocks.com and
www.MiningSectorStocks.com, portals within the InvestorIdeas.com® content umbrella,
feature industry and stock news, exclusive articles and financial columnists, audio interviews
and podcasts, investor conferences, blogs, and a directory of stocks in the sector. Industry
participants are invited to submit news, articles and research.

Mining Stocks Directory: Research mining stocks and gold stocks:
http://www.investorideas.com/membership/

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal
specialized in sector investing, covering leading industry sectors including energy and mining
stocks, in addition to global markets including China, India, the Middle East and Australia.
Investorideas.com is known for its comprehensive stock directories in each sector and sector
specific newswires.

Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Running Fox
Resource Corp. (TSX.V: RUN) for three days or press release services (seven hundred) Investorideas.com is a third
party publisher of news and research .Our sites do not make recommendations, but offer information portals to research
news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to
buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently
compensated by featured companies, news submissions and online advertising.

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

For Additional Information about Investorideas.com energy portals: 800-665-0411 or
cvanzant@investorideas.com

Oil and Gas Stocks Trading Alert; Aroway Energy Inc. (TSX.V: ARW) Continues Drilling Success in 2011

CALGARY, ALBERTA - March 22, 2011 (Investorideas.com Newswire) - AROWAY ENERGY INC. (TSX VENTURE:ARW; PINK SHEETS:ARWJF) (the "Company") Further to its March 3, 2011 news release, the Company provides the following update on its 2011 joint venture drilling operations in the Peace River Arch area of Alberta. The Company's first well of the 2011 exploration program has now been drilled, cased and completed and is awaiting pipeline tie-in. This multi-prospect exploration well was drilled to an approximate depth of 2300 meters targeting the Leduc formation. The Company is paying 50% of all costs associated with this well to earn a 50% interest in the well. Upon completion of the tie-in to its joint venture partner's pipeline and facilities, stabilized production numbers for this successful well will be released.

Drilling operations have begun on the Company's second Leduc exploration well. The multi-prospective well will be drilled to an approximate depth of 2260 meters targeting the Leduc formation. The 3D seismically defined multi-zone prospective well is also being operated by the Company's joint venture farm in partner with the Company paying 75% of all costs associated with this well to earn a 50% interest in the well. This exploration well is expected to take approximately 10 days to reach total depth.
These are the first two of a possible six wells planned for the joint venture partnership's 2011 drill program. All of the planned exploration and/or development wells to be drilled are defined by 3D seismic, have multi-zone prospectivity, and are close to infrastructure.
About Aroway Energy Inc.:
Aroway Energy Inc. is junior oil and gas exploration Company focused on high working interest non-operated oil and gas exploration prospects. Aroway is currently participating in two exploration wells which are programmed to a total depth into the Leduc formation in the Peace River Arch area of Alberta. The Company will pay 75% of all costs to earn 50% of all revenues in the exploration program.
ON BEHALF OF AROWAY ENERGY INC.
Chris Cooper, President
BOEs may be misleading, particularly if used in isolation. A BOE conversion ratio of 6 Mcf: 1bbl is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Aroway Energy Inc
Judy-Ann Pottinger
Aroway Energy Inc.
(604) 304-4090 or Cell: (604) 617-5290
(604) 909-2679 (FAX)
jpottinger@arowayenergy.com
www.arowayenergy.com
(647) 258-3311 or Toll Free: (888) 258-3323
Investor Cubed Inc.
(416) 363-7977 (FAX)
info@investor3.ca
Disclosure: ARW is a paid advertising client on Investorideas.com and our energy, natural gas, and oil and gas portals.

Visit the ARW showcase profile at Investorideas.com
Request News and Info on ARW

Security Stocks; Visualant (OTCBB:VSUL) Subsidiary TransTech Systems Obtains Exclusive Department of Homeland Security Distribution Deal

SEATTLE - March 22, 2011 (Investorideas.com Defense Newswire) - Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading color-based identification and diagnostic solutions, an emerging leader in security and authentication systems technology and distributor of a wide variety of security solutions through its wholly owned subsidiary, TransTech Systems, Inc., is pleased to announce that TransTech Systems has become the exclusive distributor to the US Federal Government of a new custom-developed proximity card programmer for use on their newly mandated identification cards.

This programmer will allow those agencies to program both 125 kHz and 13.56 MHz access control cards to match the current format in use at any particular facility, and will eliminate the expense for those agencies to have the cards individually programmed by the proximity chip manufacture prior to delivery. Agencies can now order standard card stock for all their facilities and not be required to purchase different formats for different locations as necessary prior to the development of this new device. As well, this offering will allow more flexibility in time and budget to the many agencies that are being forced to consider expensive upgrades to their existing access control systems in order to comply with the HSPD-12 presidential directive that all federal employees carry a specific type of access card, referred to as Personal Identity Verification ("PIV").
Jim Gingo, TransTech President stated, "This product will be supplied to the Department of Homeland Security ("DHS") on an exclusive basis. This order is indicative of our ongoing commitment to and support of the many DHS agencies with which we work with the ultimate goal of assisting them to save money and better work within the constraints of severely reduced funding."
Ron Erickson, Visualant CEO said, "TransTech has a respected reputation for excellence in the security and authentication marketplace. The work that Jim Gingo and his team perform for our nation’s government is first rate and helps provide the security that we demand for our country."
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com

Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs. (2500 per month)

Consumer/ Retail Stocks; YesDTC (OTCBB:YESD) Receives $500,000 Credit Line to Expand WordSmart Advertising, Driving Additional Revenue Growth -- Investor Update

SAN FRANCISCO - March 22, 2011 (Investorideas.com newswire) - YesDTC Holdings, Inc. (OTCBB:YESD), a direct-to-consumer marketer and global distributor of consumer goods and products, today announced it has obtained a new credit line of up to $500,000 for media purchasing. The credit line is being utilized beginning this week to finance a sizably increased budget for advertising the Company's flagship WordSmart product line, a development that holds significance given that over 90% of the WordSmart revenues come from television advertising.

"This is a very important event for us," commented Joseph Noel, CEO of YesDTC. "Since acquiring the WordSmart show, we have been producing a solid media efficiency ratio (MER) which corresponds to revenue generated for each dollar spent on media. With a strong, reliable MER, the direct response revenue generation model becomes relatively simple -- spending more on media will produce more revenues." Mr. Noel continued, "With this new financing resource, we will be able to further increase the airing frequency of the thirty-minute WordSmart infomercial hosted by Alex Trebek of Jeopardy! Next week, we plan to double our WordSmart media spending, with an almost additional doubling the following week."
Mr. Noel, continued, "While these events are very exciting, and given the WordSmart program will likely be a significant revenue producer this year, we do not think it will be our biggest revenue producer. We are planning to launch our MotorBooster engine conditioner product during the Memorial Day weekend and, considering the rising price of fuel, we believe revenue from this new fuel saving product could easily surpass the robust results produced by WordSmart. Additionally, our PureSleep anti-snoring product, which launched in China a few days ago, could represent meaningful upside potential. We believe this product is well positioned in the marketplace considering that it is an FDA cleared device made from U.S. produced plastics that is now going head-to-head with vastly inferior Chinese designed and manufactured products at the same pricing level."
"Over the next few weeks, we also plan to restart the advertising program for the MediPendant personal medical alarm in conjunction with our joint venture partner, Medical Alarm Concepts Holding, Inc. (OTCQB:MDHI). Recent tests showed very strong sales. We have re-cut the 120-second MediPendant commercial into a 60-second format, which we believe will produce even better results. We are also proceeding with the NutriFusion product via an upcoming retail placement in up to 300 Mannings drugstores in Hong Kong. We remain very excited about our growth prospects this year," concluded Mr. Noel.
YesDTC's growing product portfolio currently includes the NutriFusion line of easy-to-consume capsule and chewable nutraceutical supplement products; WordSmart, the knowledge and vocabulary building program sponsored by Alex Trebek of Jeopardy!; PureSleep Asia, the U.S. FDA-cleared anti-snoring dental device for the treatment of snoring, and MediPendant(TM), the only speak and listen through the pendant medical alarm system. The Company's infomercials for MediPendant and WordSmart can be seen at www.medipendant.com, and http://www.vimeo.com/16363930, respectively. More information on NutriFusion can be seen at www.nutrifusion.com
About YesDTC Holdings, Inc.
YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.
Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.
Contact:
YesDTC Holdings, Inc.
Christian Kirsebom
(925) 247-6666
Contact Investorideas.com
dvanzant@investorideas.com
Visit the YESD showcase profile at Investorideas.com
http://www.investorideas.com/CO/YESD/
Request News and Info on YESD
Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com.
YESD: one time fee of five thousand cash and three hundred thousand 144 shares
About Investorideas.com
- Investor Ideas the can change the world

Sign up for free stock alerts and news:
http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics
Investor Protection and Regulation for Pinks sheets: http://www.pinksheets.com/otcguide/investors_protection.jsp

Ronald Erickson, CEO, of Visualant Inc. (OTCBB: VSUL), Discusses the Power and
Accuracy of its Patent Pending Sensor Technology

Multiple Market Applications For Spectral Pattern Matching Technology Include Homeland
Security, Identity Theft, Environmental and Agricultural

Point Roberts, WA- March 22, 2011 – Investorideas.com, an investor research portal
specializing in sector research, including security stocks, presents a Q&A interview featuring Mr.
Ronald Erickson, CEO, President and Chairman of the Board of Visualant, Inc. (OTCBB:VSUL).

Visualant’s patent pending ‘Spectral Pattern Matching’ technology uses light to create a unique
signature for individual items and classes of items, including a recent environmental application to
identify oil in water.

Interview:

Q: Investorideas.com
Ron, according to your corporate description, your sensor technology offers the simplest, fastest
and most inexpensive means to document unique non-visible signatures from nearly any kind of
product or surface. What kind of results and feedback are you seeing with the technology as your
applications widen into new markets?

A: Ronald Erickson, CEO, President and Chairman of the Board

As we continue our work in the laboratory we are discovering some rather startling results. For
example, this past week we were able to differentiate between ten brands of vodka. I don’t
expect that to be a business focus for us. It simply illustrates the power of the Spectral Pattern
Technology to detect the unique differences that exist between substances that appear identical
to the human eye.

Q: Investorideas.com
With some of the most recent applications in conjunction with your licensed partner, Javelin LLC,
you are detecting oil in water. To what level of accuracy and to what degree can your technology
detect the oil?

A: Ronald Erickson, CEO, President and Chairman of the Board

In the laboratory test setting we have been able to detect miniscule amounts of oil or adulterates
in oil. The laboratory tests have provided evidence of an acceptable level of accuracy.

Q: Investorideas.com
From an accuracy and efficiency standpoint, who would you say your nearest competitors are in
the sensor market? And how do you compare?

A: Ronald Erickson, CEO, President and Chairman of the Board

There are any number of competitors providing competitive products in the senor market. We
believe that we have a distinct competitive advantage because of our low cost model and the
flexibility and durability of our technology.

Q: Investorideas.com
How does your technology enhance and improve overall security by adding it to current
biometrics technology?

A: Ronald Erickson, CEO, President and Chairman of the Board

The Visualant Spectral Pattern Technology adds an additional layer of authentication and
requires no added features such as an RFID chip, taggant, thread or hologram. We simply see
that color that is present.

Q: Investorideas.com
In terms of new applications, is there ongoing testing and R&D to develop new markets internally
at Visualant or do you work with partners and companies that license the technology to build this
out ?

A: Ronald Erickson, CEO, President and Chairman of the Board

We do both. We are working on a Spectral Pattern Matching Development Kit which third parties
can use to develop their own applications. We are also working on some product ideas at
Visualant which we will bring to market ourselves and in conjunction with joint venture partners.

Q: Investorideas.com
In terms of potential new partners and markets, what industry sector are you seeing the most
interest and activity in? And why do you think that is?

A. Ronald Erickson, CEO, President and Chairman of the Board

Naturally, given the focus of our TransTech subsidiary on the security and authentication
marketplace we are seeing most of our activity in that sector. It is an extremely important part of
the market.

About Visualant, Inc. (OTCBB: VSUL)
Visualant, Inc. develops low-cost, high speed, light-based security and quality control solutions
for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and
process control applications. Its patent-pending technology uses controlled illumination with
specific bands of light, to establish a unique spectral signature for both individual and classes
of items. When matched against existing databases, these spectral signatures allow precise
identification and authentication of any item or substance. This breakthrough optical sensing
and data capture technology is called Spectral Pattern Matching (SPM). SPM technology can be
miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and
can be combined in the same package as a bar-code or biometric scanner. www.visulant.net

Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security
and authentication solutions to security and law enforcement markets throughout the United
States. www.ttsys.com

Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net

Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com

Visit the company profile on Investorideas.com
http://www.investorideas.com/CO/VSUL/

About InvestorIdeas.com:

InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector
investing, covering leading industry sectors including defense stocks, energy stocks, mining and gold
stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com
is known for its comprehensive stock directories in each sector and sector specific newswires.

Get investor alerts for VSUL:

http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer:
This news is paid for as part of the showcase advertising program for Visualant, Inc. (OTCBB: VSUL)
Visualant is a featured showcase company on Investorideas.com and related security portals and blogs.
The cost for this service is Two thousand five Dollars per month which has been paid by a third party. Our
sites do not make recommendations, but offer information portals to research news, articles, stock lists and
recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products
or securities. All information on showcase companies is taken from public documents, news, filings and
the company website and management. This site is currently compensated by featured companies, news
submissions and online advertising. Investors are reminded all investment involves risk including possible
loss of principal. Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Contact Investorideas.com
dvanzant@investorideas.com 800 665 0411

The Shift to Environmental Stocks; (NasdaqGS: BWEN ), .(NasdaqGS: FSLR ), (NYSE: STP ), (NYSE:
YGE )

Company Snapshots for Abtech Holdings (OTC.BB:ABHD), Clean Wind Energy Tower, Inc.
(OTCBB: CWET)

Point Roberts, WA –March 21, 2011 - Investorideas.com, a leader in cleantech stock research, reports on
morning trading for March 21. Investors continue to turn to cleantech stocks following the nuclear disaster
in Japan. In morning trading, equities, oil and gold were all up, giving investors green in all market
segments.

Green Stocks Snapshot; Morning Trading
Abtech Holdings (OTCBB:ABHD ) trading at $1.32 , up 0.05 (3.94%)
Broadwind Energy, Inc. (NasdaqGS: BWEN ) trading at $1.46, up 0.01 (0.69%) 10:31AM EDT
Clean Wind Energy Tower, Inc. (OTCBB: CWET) trading at $0.24
First Solar, Inc.(NasdaqGS: FSLR ) trading at $151.47, up 1.81 (1.21%) 10:31AM EDT
Suntech Power Holdings (NYSE: STP ) trading at $8.7, up 0.23 (2.69%) 10:31AM EDT
Yingli Green Energy Holding (NYSE: YGE ) trading at $11.81, up 0.28 (2.43%) 10:41AM EDT

Market Snapshot
Dow 12,048.22 +189.70 +1.60%
NASDAQ 2,693.38 +49.71 +1.88%
S&P 500 1,297.75 +18.55 +1.45%
10 Yr Bond(%) 3.3470% +0.0700
Oil 101.73 +0.72 +0.71%
Gold 1,433.50 +17.60 +1.24%

Research more green stocks with the renewable energy stocks directory:

http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp

Environmental Company Snapshot
About Abtech Holdings (OTC.BB:ABHD ) and AbTech Industries
AbTech Industries, Inc. (a subsidiary of Abtech Holdings Inc.) is an environmental technologies firm
dedicated to providing innovative solutions to communities, industry and governments addressing
issues of water pollutants and contamination. Its products are based on polymer technologies capable
of removing hydrocarbons, sediment and other foreign elements from still (ponds, lakes and marinas)
or flowing water (curbside drains, pipe outflows, rivers and oceans). Smart Sponge Plus contains
an antimicrobial agent that is effective in reducing coliform bacteria found in stormwater, industrial
wastewater and municipal wastewater. AbTech's Smart Sponge technology is installed in more than
15,000 locations across America and in 8 countries worldwide.
www.abtechindustries.com

Wind Company Snapshot

Clean Wind Energy Tower, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., was established
to commercialize a number of proven and validated technologies and construction systems into a single
large downdraft tower structure that use benevolent, non-toxic natural elements to generate electricity

and clean water economically by integrating and synthesizing numerous proven as well as emerging
technologies. In addition to constructing Downdraft Towers in the United States and abroad, Clean Wind
Energy, Inc. has assembled a world class team of experienced business professionals, engineers and
scientists with access to the breakthrough energy research upon which this technology is founded and
the proven ability to bring the idea to market.

Clean Wind has filed several patents that the Company believes will further enhance this potentially
revolutionary technology. The Company intends to establish partnerships at home and abroad to
propagate these systems and meet increasing global demand for clean water and electricity.
www.cleanwindenergytower.com

Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Recent News:

Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files Unique Hydraulic System Patent

Maximizing the Capture and Use of Available Wind Tunnel Energy

ANNAPOLIS, MD - March 7, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc.
(OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark
Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled
Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying
multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high
efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is
to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as
providing a consistency of power output during deviations in wind speed.
Full news: http://www.investorideas.com/CO/CWE/news/2011/03071.asp

About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy
stocks and has become a global go-to destination for investors researching the cleantech sector, with
stock directories, company news, commentary from experts, research reports and industry resources and
links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.

Sign up at Investor Ideas for free investor alerts including news on (OTCBB: CWET)
http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET)
advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one
thousand five hundred per month, 100,000 144 shares ) to be showcased as a renewable energy stock within its
hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer
or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees
as to the accuracy of information presented. All Information relating to featured companies is sourced from public
documents and/ or the company and its management and is not the opinion of Investorideas.com.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp

For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com